|
RPA2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.998800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.030200E-04 |
| Normal-vs-Stage2 |
3.176000E-03 |
| Normal-vs-Stage3 |
6.380400E-03 |
| Normal-vs-Stage4 |
2.344100E-03 |
| Stage1-vs-Stage2 |
5.121800E-01 |
| Stage1-vs-Stage3 |
8.288600E-01 |
| Stage1-vs-Stage4 |
5.658600E-01 |
| Stage2-vs-Stage3 |
4.751800E-01 |
| Stage2-vs-Stage4 |
9.344200E-01 |
| Stage3-vs-Stage4 |
5.132800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.622540E-03 |
| Normal-vs-AfricanAmerican |
8.442100E-02 |
| Normal-vs-Asian |
2.316900E-03 |
| Caucasian-vs-AfricanAmerican |
6.351000E-01 |
| Caucasian-vs-Asian |
8.142400E-01 |
| AfricanAmerican-vs-Asian |
5.284400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.441200E-04 |
| Normal-vs-Female |
1.195850E-03 |
| Male-vs-Female |
1.638850E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.019900E-03 |
| Normal-vs-Age(41-60Yrs) |
4.135700E-03 |
| Normal-vs-Age(61-80Yrs) |
5.213600E-04 |
| Normal-vs-Age(81-100Yrs) |
1.772020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.975400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.278800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.920400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.763800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.006400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.615800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.684200E-01 |
| Classical-VS-Follicular |
1.365820E-01 |
| Classical-VS-Other |
1.781970E-01 |
| Classical-VS-Normal |
6.475800E-03 |
| Tall-VS-Follicular |
5.046800E-01 |
| Tall-VS-Other |
2.865800E-01 |
| Tall-VS-Normal |
1.900310E-02 |
| Follicular-VS-Other |
5.886200E-01 |
| Follicular-VS-Normal |
8.400900E-04 |
| Other-VS-Normal |
1.078400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.385900E-04 |
| Normal-vs-N1 |
2.562900E-04 |
| N0-vs-N1 |
1.959230E-01 |
|
|
